Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase

Bioorg Med Chem Lett. 2009 Jan 1;19(1):153-7. doi: 10.1016/j.bmcl.2008.10.129. Epub 2008 Nov 5.

Abstract

Mur ligases catalyze the biosynthesis of the UDP-MurNAc-pentapeptide precursor of peptidoglycan, an essential polymer of bacterial cell-wall. They constitute attractive targets for the development of novel antibacterial agents. Here we report on the synthesis of a series of 2,4-diaminoquinazolines, quinazoline-2,4(1H,3H)-diones, 5-benzylidenerhodanines and 5-benzylidenethiazolidine-2,4-diones and their inhibitory activities against MurD from Escherichia coli. Compounds (R)-27 and (S)-27 showed inhibitory activity against MurD with IC(50) values of 174 and 206 microM, respectively, which makes them promising starting points for optimization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis*
  • Anti-Bacterial Agents / pharmacology
  • Benzylidene Compounds / chemical synthesis
  • Benzylidene Compounds / pharmacology
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / pharmacology
  • Escherichia coli / enzymology
  • Glutamic Acid
  • Inhibitory Concentration 50
  • Peptide Synthases / antagonists & inhibitors*
  • Quinazolines / chemical synthesis
  • Quinazolines / pharmacology

Substances

  • Anti-Bacterial Agents
  • Benzylidene Compounds
  • Enzyme Inhibitors
  • Quinazolines
  • Glutamic Acid
  • Peptide Synthases
  • UDP-N-acetylmuramoylalanine-D-glutamate ligase